nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—Estradiol—osteoporosis	0.0884	0.162	CbGbCtD
Argatroban—CYP3A4—Estropipate—osteoporosis	0.083	0.152	CbGbCtD
Argatroban—CYP3A4—Calcitriol—osteoporosis	0.083	0.152	CbGbCtD
Argatroban—CYP3A4—Ergocalciferol—osteoporosis	0.0664	0.122	CbGbCtD
Argatroban—CYP3A4—Raloxifene—osteoporosis	0.0554	0.101	CbGbCtD
Argatroban—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0535	0.0979	CbGbCtD
Argatroban—CYP3A4—Cholecalciferol—osteoporosis	0.0428	0.0783	CbGbCtD
Argatroban—CYP3A4—Conjugated Estrogens—osteoporosis	0.0393	0.0719	CbGbCtD
Argatroban—CYP3A4—Estradiol—osteoporosis	0.0345	0.0631	CbGbCtD
Argatroban—F2—Common Pathway—FGA—osteoporosis	0.00432	0.0435	CbGpPWpGaD
Argatroban—F2—Common Pathway—FGB—osteoporosis	0.00393	0.0396	CbGpPWpGaD
Argatroban—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00377	0.038	CbGpPWpGaD
Argatroban—F2—Blood Clotting Cascade—FGA—osteoporosis	0.00368	0.0371	CbGpPWpGaD
Argatroban—F2—Blood Clotting Cascade—FGB—osteoporosis	0.00334	0.0337	CbGpPWpGaD
Argatroban—F2—Platelet Aggregation (Plug Formation)—TLN1—osteoporosis	0.00324	0.0327	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—PRDX3—osteoporosis	0.00272	0.0274	CbGpPWpGaD
Argatroban—F2—Platelet Aggregation (Plug Formation)—RAP1A—osteoporosis	0.00267	0.027	CbGpPWpGaD
Argatroban—F2—Formation of Fibrin Clot (Clotting Cascade)—FGA—osteoporosis	0.00248	0.025	CbGpPWpGaD
Argatroban—F2—Platelet Aggregation (Plug Formation)—FGA—osteoporosis	0.00243	0.0244	CbGpPWpGaD
Argatroban—F2—Formation of Fibrin Clot (Clotting Cascade)—FGB—osteoporosis	0.00226	0.0227	CbGpPWpGaD
Argatroban—F2—Platelet Aggregation (Plug Formation)—FGB—osteoporosis	0.00221	0.0222	CbGpPWpGaD
Argatroban—F2—Regulation of IGF Activity by IGFBP—IGF1—osteoporosis	0.00157	0.0158	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.00157	0.0158	CbGpPWpGaD
Argatroban—F2—Complement and Coagulation Cascades—FGB—osteoporosis	0.00152	0.0153	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—GSN—osteoporosis	0.00152	0.0153	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.00124	0.0125	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—SOD2—osteoporosis	0.00114	0.0115	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—MGLL—osteoporosis	0.00113	0.0113	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—IL1B—osteoporosis	0.00109	0.011	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—VCL—osteoporosis	0.00105	0.0106	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—ACTG1—osteoporosis	0.00105	0.0106	CbGpPWpGaD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00103	0.0104	CbGpPWpGaD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00102	0.0102	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.00101	0.0101	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.001	0.0101	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000985	0.00993	CbGpPWpGaD
Argatroban—Back pain—Ibandronate—osteoporosis	0.000945	0.00266	CcSEcCtD
Argatroban—Haematuria—Pamidronate—osteoporosis	0.000933	0.00263	CcSEcCtD
Argatroban—Vomiting—Calcium Acetate—osteoporosis	0.00093	0.00262	CcSEcCtD
Argatroban—Haemoglobin—Risedronate—osteoporosis	0.000929	0.00262	CcSEcCtD
Argatroban—F2—Folate Metabolism—SOD2—osteoporosis	0.000929	0.00936	CbGpPWpGaD
Argatroban—Haemorrhage—Risedronate—osteoporosis	0.000924	0.00261	CcSEcCtD
Argatroban—Cerebrovascular accident—Estradiol—osteoporosis	0.000913	0.00257	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000901	0.00908	CbGpPWpGaD
Argatroban—Cough—Estropipate—osteoporosis	0.000889	0.00251	CcSEcCtD
Argatroban—F2—Folate Metabolism—GPX1—osteoporosis	0.000886	0.00893	CbGpPWpGaD
Argatroban—Haemoglobin—Pamidronate—osteoporosis	0.000883	0.00249	CcSEcCtD
Argatroban—Haemorrhage—Pamidronate—osteoporosis	0.000879	0.00248	CcSEcCtD
Argatroban—Urinary tract infection—Zoledronate—osteoporosis	0.000869	0.00245	CcSEcCtD
Argatroban—Nausea—Calcium Acetate—osteoporosis	0.000869	0.00245	CcSEcCtD
Argatroban—Cough—Raloxifene—osteoporosis	0.000861	0.00243	CcSEcCtD
Argatroban—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00086	0.00243	CcSEcCtD
Argatroban—Chest pain—Alendronate—osteoporosis	0.000854	0.00241	CcSEcCtD
Argatroban—Haematuria—Zoledronate—osteoporosis	0.000853	0.0024	CcSEcCtD
Argatroban—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.000849	0.00239	CcSEcCtD
Argatroban—Dyspepsia—Etidronic acid—osteoporosis	0.000846	0.00238	CcSEcCtD
Argatroban—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.000844	0.00238	CcSEcCtD
Argatroban—Chest pain—Raloxifene—osteoporosis	0.00084	0.00237	CcSEcCtD
Argatroban—Angiopathy—Risedronate—osteoporosis	0.000839	0.00236	CcSEcCtD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000835	0.00841	CbGpPWpGaD
Argatroban—Chest pain—Ibandronate—osteoporosis	0.000831	0.00234	CcSEcCtD
Argatroban—Infection—Estropipate—osteoporosis	0.000826	0.00233	CcSEcCtD
Argatroban—Constipation—Etidronic acid—osteoporosis	0.000821	0.00232	CcSEcCtD
Argatroban—F2—Folate Metabolism—MTHFR—osteoporosis	0.000817	0.00824	CbGpPWpGaD
Argatroban—Bradycardia—Zoledronate—osteoporosis	0.000817	0.0023	CcSEcCtD
Argatroban—Chest pain—Calcitriol—osteoporosis	0.000814	0.00229	CcSEcCtD
Argatroban—Infection—Alendronate—osteoporosis	0.000813	0.00229	CcSEcCtD
Argatroban—F2—Hemostasis—WDR1—osteoporosis	0.000809	0.00815	CbGpPWpGaD
Argatroban—Infection—Raloxifene—osteoporosis	0.0008	0.00225	CcSEcCtD
Argatroban—Back pain—Ethinyl Estradiol—osteoporosis	0.000798	0.00225	CcSEcCtD
Argatroban—Angiopathy—Pamidronate—osteoporosis	0.000797	0.00225	CcSEcCtD
Argatroban—Infection—Ibandronate—osteoporosis	0.000792	0.00223	CcSEcCtD
Argatroban—Feeling abnormal—Etidronic acid—osteoporosis	0.000792	0.00223	CcSEcCtD
Argatroban—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000786	0.00221	CcSEcCtD
Argatroban—Back pain—Risedronate—osteoporosis	0.000778	0.00219	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000777	0.00783	CbGpPWpGaD
Argatroban—Nausea—Ergocalciferol—osteoporosis	0.000768	0.00216	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000766	0.00772	CbGpPWpGaD
Argatroban—Abdominal pain—Etidronic acid—osteoporosis	0.000759	0.00214	CcSEcCtD
Argatroban—Back pain—Pamidronate—osteoporosis	0.00074	0.00209	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—SOD2—osteoporosis	0.000738	0.00743	CbGpPWpGaD
Argatroban—Dyspepsia—Estropipate—osteoporosis	0.000732	0.00206	CcSEcCtD
Argatroban—Angiopathy—Zoledronate—osteoporosis	0.000728	0.00205	CcSEcCtD
Argatroban—Dyspepsia—Alendronate—osteoporosis	0.000721	0.00203	CcSEcCtD
Argatroban—Cough—Ethinyl Estradiol—osteoporosis	0.00072	0.00203	CcSEcCtD
Argatroban—Gastrointestinal disorder—Estropipate—osteoporosis	0.000717	0.00202	CcSEcCtD
Argatroban—F2—GPCR ligand binding—PTH1R—osteoporosis	0.000715	0.0072	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CALCR—osteoporosis	0.000715	0.0072	CbGpPWpGaD
Argatroban—Pain—Estropipate—osteoporosis	0.000711	0.002	CcSEcCtD
Argatroban—Constipation—Estropipate—osteoporosis	0.000711	0.002	CcSEcCtD
Argatroban—Dyspepsia—Raloxifene—osteoporosis	0.000709	0.002	CcSEcCtD
Argatroban—Hypersensitivity—Etidronic acid—osteoporosis	0.000708	0.002	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—GPX1—osteoporosis	0.000704	0.00709	CbGpPWpGaD
Argatroban—Cough—Risedronate—osteoporosis	0.000702	0.00198	CcSEcCtD
Argatroban—Dyspepsia—Ibandronate—osteoporosis	0.000702	0.00198	CcSEcCtD
Argatroban—Angiopathy—Conjugated Estrogens—osteoporosis	0.000701	0.00198	CcSEcCtD
Argatroban—Pain—Alendronate—osteoporosis	0.0007	0.00197	CcSEcCtD
Argatroban—Constipation—Alendronate—osteoporosis	0.0007	0.00197	CcSEcCtD
Argatroban—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000695	0.00196	CcSEcCtD
Argatroban—Pneumonia—Estradiol—osteoporosis	0.000693	0.00195	CcSEcCtD
Argatroban—Pain—Raloxifene—osteoporosis	0.000688	0.00194	CcSEcCtD
Argatroban—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000688	0.00194	CcSEcCtD
Argatroban—Chest pain—Risedronate—osteoporosis	0.000685	0.00193	CcSEcCtD
Argatroban—Constipation—Ibandronate—osteoporosis	0.000682	0.00192	CcSEcCtD
Argatroban—Pain—Ibandronate—osteoporosis	0.000682	0.00192	CcSEcCtD
Argatroban—Gastrointestinal pain—Estropipate—osteoporosis	0.00068	0.00192	CcSEcCtD
Argatroban—Acute coronary syndrome—Estradiol—osteoporosis	0.000679	0.00192	CcSEcCtD
Argatroban—Back pain—Zoledronate—osteoporosis	0.000676	0.00191	CcSEcCtD
Argatroban—Myocardial infarction—Estradiol—osteoporosis	0.000675	0.0019	CcSEcCtD
Argatroban—Feeling abnormal—Alendronate—osteoporosis	0.000675	0.0019	CcSEcCtD
Argatroban—Urinary tract infection—Estradiol—osteoporosis	0.00067	0.00189	CcSEcCtD
Argatroban—Gastrointestinal pain—Alendronate—osteoporosis	0.000669	0.00189	CcSEcCtD
Argatroban—Infection—Ethinyl Estradiol—osteoporosis	0.000669	0.00189	CcSEcCtD
Argatroban—Cough—Pamidronate—osteoporosis	0.000668	0.00188	CcSEcCtD
Argatroban—Pain—Calcitriol—osteoporosis	0.000667	0.00188	CcSEcCtD
Argatroban—Constipation—Calcitriol—osteoporosis	0.000667	0.00188	CcSEcCtD
Argatroban—Gastrointestinal pain—Raloxifene—osteoporosis	0.000658	0.00186	CcSEcCtD
Argatroban—Diarrhoea—Etidronic acid—osteoporosis	0.000657	0.00185	CcSEcCtD
Argatroban—Haematuria—Estradiol—osteoporosis	0.000657	0.00185	CcSEcCtD
Argatroban—Abdominal pain—Estropipate—osteoporosis	0.000657	0.00185	CcSEcCtD
Argatroban—Body temperature increased—Estropipate—osteoporosis	0.000657	0.00185	CcSEcCtD
Argatroban—Feeling abnormal—Ibandronate—osteoporosis	0.000657	0.00185	CcSEcCtD
Argatroban—Infection—Risedronate—osteoporosis	0.000652	0.00184	CcSEcCtD
Argatroban—Gastrointestinal pain—Ibandronate—osteoporosis	0.000652	0.00184	CcSEcCtD
Argatroban—Back pain—Conjugated Estrogens—osteoporosis	0.000651	0.00183	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000649	0.00654	CbGpPWpGaD
Argatroban—Abdominal pain—Alendronate—osteoporosis	0.000647	0.00182	CcSEcCtD
Argatroban—Body temperature increased—Alendronate—osteoporosis	0.000647	0.00182	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.00064	0.00645	CbGpPWpGaD
Argatroban—F2—Hemostasis—CAP1—osteoporosis	0.000639	0.00644	CbGpPWpGaD
Argatroban—Gastrointestinal pain—Calcitriol—osteoporosis	0.000638	0.0018	CcSEcCtD
Argatroban—Abdominal pain—Raloxifene—osteoporosis	0.000636	0.00179	CcSEcCtD
Argatroban—Body temperature increased—Raloxifene—osteoporosis	0.000636	0.00179	CcSEcCtD
Argatroban—Abdominal pain—Ibandronate—osteoporosis	0.00063	0.00178	CcSEcCtD
Argatroban—Body temperature increased—Ibandronate—osteoporosis	0.00063	0.00178	CcSEcCtD
Argatroban—Confusional state—Pamidronate—osteoporosis	0.00063	0.00177	CcSEcCtD
Argatroban—Haemoglobin—Estradiol—osteoporosis	0.000622	0.00175	CcSEcCtD
Argatroban—Infection—Pamidronate—osteoporosis	0.00062	0.00175	CcSEcCtD
Argatroban—Haemorrhage—Estradiol—osteoporosis	0.000619	0.00174	CcSEcCtD
Argatroban—Abdominal pain—Calcitriol—osteoporosis	0.000617	0.00174	CcSEcCtD
Argatroban—Body temperature increased—Calcitriol—osteoporosis	0.000617	0.00174	CcSEcCtD
Argatroban—Hypersensitivity—Estropipate—osteoporosis	0.000612	0.00173	CcSEcCtD
Argatroban—Vomiting—Etidronic acid—osteoporosis	0.000611	0.00172	CcSEcCtD
Argatroban—Cough—Zoledronate—osteoporosis	0.00061	0.00172	CcSEcCtD
Argatroban—Tachycardia—Pamidronate—osteoporosis	0.000609	0.00172	CcSEcCtD
Argatroban—Rash—Etidronic acid—osteoporosis	0.000606	0.00171	CcSEcCtD
Argatroban—Dermatitis—Etidronic acid—osteoporosis	0.000605	0.00171	CcSEcCtD
Argatroban—Hypersensitivity—Alendronate—osteoporosis	0.000603	0.0017	CcSEcCtD
Argatroban—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000603	0.00608	CbGpPWpGaD
Argatroban—Headache—Etidronic acid—osteoporosis	0.000602	0.0017	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—IL1B—osteoporosis	0.000596	0.00601	CbGpPWpGaD
Argatroban—Chest pain—Zoledronate—osteoporosis	0.000595	0.00168	CcSEcCtD
Argatroban—Hypersensitivity—Ibandronate—osteoporosis	0.000587	0.00166	CcSEcCtD
Argatroban—Cough—Conjugated Estrogens—osteoporosis	0.000587	0.00166	CcSEcCtD
Argatroban—Dyspnoea—Risedronate—osteoporosis	0.000586	0.00165	CcSEcCtD
Argatroban—Hypotension—Pamidronate—osteoporosis	0.000583	0.00164	CcSEcCtD
Argatroban—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000582	0.00164	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000581	0.00585	CbGpPWpGaD
Argatroban—Dyspepsia—Risedronate—osteoporosis	0.000578	0.00163	CcSEcCtD
Argatroban—Constipation—Ethinyl Estradiol—osteoporosis	0.000576	0.00162	CcSEcCtD
Argatroban—Confusional state—Zoledronate—osteoporosis	0.000575	0.00162	CcSEcCtD
Argatroban—Hypersensitivity—Calcitriol—osteoporosis	0.000575	0.00162	CcSEcCtD
Argatroban—Chest pain—Conjugated Estrogens—osteoporosis	0.000573	0.00162	CcSEcCtD
Argatroban—Nausea—Etidronic acid—osteoporosis	0.000571	0.00161	CcSEcCtD
Argatroban—Diarrhoea—Estropipate—osteoporosis	0.000569	0.0016	CcSEcCtD
Argatroban—Gastrointestinal disorder—Risedronate—osteoporosis	0.000567	0.0016	CcSEcCtD
Argatroban—Infection—Zoledronate—osteoporosis	0.000567	0.0016	CcSEcCtD
Argatroban—Constipation—Risedronate—osteoporosis	0.000562	0.00158	CcSEcCtD
Argatroban—Pain—Risedronate—osteoporosis	0.000562	0.00158	CcSEcCtD
Argatroban—Angiopathy—Estradiol—osteoporosis	0.000561	0.00158	CcSEcCtD
Argatroban—Diarrhoea—Alendronate—osteoporosis	0.00056	0.00158	CcSEcCtD
Argatroban—Dyspnoea—Pamidronate—osteoporosis	0.000557	0.00157	CcSEcCtD
Argatroban—Tachycardia—Zoledronate—osteoporosis	0.000557	0.00157	CcSEcCtD
Argatroban—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000555	0.00157	CcSEcCtD
Argatroban—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000551	0.00155	CcSEcCtD
Argatroban—Diarrhoea—Raloxifene—osteoporosis	0.000551	0.00155	CcSEcCtD
Argatroban—Dyspepsia—Pamidronate—osteoporosis	0.00055	0.00155	CcSEcCtD
Argatroban—Dizziness—Estropipate—osteoporosis	0.00055	0.00155	CcSEcCtD
Argatroban—Infection—Conjugated Estrogens—osteoporosis	0.000546	0.00154	CcSEcCtD
Argatroban—Diarrhoea—Ibandronate—osteoporosis	0.000545	0.00154	CcSEcCtD
Argatroban—Dizziness—Alendronate—osteoporosis	0.000541	0.00153	CcSEcCtD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000541	0.00545	CbGpPWpGaD
Argatroban—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000539	0.00152	CcSEcCtD
Argatroban—Gastrointestinal pain—Risedronate—osteoporosis	0.000537	0.00151	CcSEcCtD
Argatroban—Tachycardia—Conjugated Estrogens—osteoporosis	0.000536	0.00151	CcSEcCtD
Argatroban—Pain—Pamidronate—osteoporosis	0.000534	0.00151	CcSEcCtD
Argatroban—Constipation—Pamidronate—osteoporosis	0.000534	0.00151	CcSEcCtD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000534	0.00538	CbGpPWpGaD
Argatroban—Diarrhoea—Calcitriol—osteoporosis	0.000534	0.0015	CcSEcCtD
Argatroban—Hypotension—Zoledronate—osteoporosis	0.000533	0.0015	CcSEcCtD
Argatroban—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000533	0.0015	CcSEcCtD
Argatroban—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000533	0.0015	CcSEcCtD
Argatroban—Dizziness—Raloxifene—osteoporosis	0.000532	0.0015	CcSEcCtD
Argatroban—Vomiting—Estropipate—osteoporosis	0.000528	0.00149	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000528	0.00532	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CCT2—osteoporosis	0.000527	0.00531	CbGpPWpGaD
Argatroban—Dizziness—Ibandronate—osteoporosis	0.000527	0.00149	CcSEcCtD
Argatroban—Rash—Estropipate—osteoporosis	0.000524	0.00148	CcSEcCtD
Argatroban—Dermatitis—Estropipate—osteoporosis	0.000524	0.00148	CcSEcCtD
Argatroban—Back pain—Estradiol—osteoporosis	0.000521	0.00147	CcSEcCtD
Argatroban—Headache—Estropipate—osteoporosis	0.000521	0.00147	CcSEcCtD
Argatroban—Vomiting—Alendronate—osteoporosis	0.00052	0.00147	CcSEcCtD
Argatroban—Abdominal pain—Risedronate—osteoporosis	0.000519	0.00146	CcSEcCtD
Argatroban—Body temperature increased—Risedronate—osteoporosis	0.000519	0.00146	CcSEcCtD
Argatroban—Rash—Alendronate—osteoporosis	0.000516	0.00146	CcSEcCtD
Argatroban—Dermatitis—Alendronate—osteoporosis	0.000516	0.00145	CcSEcCtD
Argatroban—Feeling abnormal—Pamidronate—osteoporosis	0.000515	0.00145	CcSEcCtD
Argatroban—Hypotension—Conjugated Estrogens—osteoporosis	0.000513	0.00145	CcSEcCtD
Argatroban—Headache—Alendronate—osteoporosis	0.000513	0.00145	CcSEcCtD
Argatroban—Vomiting—Raloxifene—osteoporosis	0.000512	0.00144	CcSEcCtD
Argatroban—Gastrointestinal pain—Pamidronate—osteoporosis	0.000511	0.00144	CcSEcCtD
Argatroban—Dyspnoea—Zoledronate—osteoporosis	0.000508	0.00143	CcSEcCtD
Argatroban—F2—Hemostasis—MGLL—osteoporosis	0.000508	0.00512	CbGpPWpGaD
Argatroban—Rash—Raloxifene—osteoporosis	0.000508	0.00143	CcSEcCtD
Argatroban—Dermatitis—Raloxifene—osteoporosis	0.000507	0.00143	CcSEcCtD
Argatroban—Vomiting—Ibandronate—osteoporosis	0.000507	0.00143	CcSEcCtD
Argatroban—Headache—Raloxifene—osteoporosis	0.000504	0.00142	CcSEcCtD
Argatroban—Rash—Ibandronate—osteoporosis	0.000502	0.00142	CcSEcCtD
Argatroban—Dermatitis—Ibandronate—osteoporosis	0.000502	0.00142	CcSEcCtD
Argatroban—Dyspepsia—Zoledronate—osteoporosis	0.000502	0.00142	CcSEcCtD
Argatroban—Headache—Ibandronate—osteoporosis	0.000499	0.00141	CcSEcCtD
Argatroban—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000496	0.0014	CcSEcCtD
Argatroban—Vomiting—Calcitriol—osteoporosis	0.000496	0.0014	CcSEcCtD
Argatroban—Nausea—Estropipate—osteoporosis	0.000494	0.00139	CcSEcCtD
Argatroban—Abdominal pain—Pamidronate—osteoporosis	0.000494	0.00139	CcSEcCtD
Argatroban—Body temperature increased—Pamidronate—osteoporosis	0.000494	0.00139	CcSEcCtD
Argatroban—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000492	0.00139	CcSEcCtD
Argatroban—Rash—Calcitriol—osteoporosis	0.000492	0.00139	CcSEcCtD
Argatroban—Dermatitis—Calcitriol—osteoporosis	0.000491	0.00139	CcSEcCtD
Argatroban—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00049	0.00138	CcSEcCtD
Argatroban—Headache—Calcitriol—osteoporosis	0.000489	0.00138	CcSEcCtD
Argatroban—Pain—Zoledronate—osteoporosis	0.000488	0.00137	CcSEcCtD
Argatroban—Constipation—Zoledronate—osteoporosis	0.000488	0.00137	CcSEcCtD
Argatroban—Nausea—Alendronate—osteoporosis	0.000486	0.00137	CcSEcCtD
Argatroban—F2—Folate Metabolism—IL1B—osteoporosis	0.000485	0.00489	CbGpPWpGaD
Argatroban—Hypersensitivity—Risedronate—osteoporosis	0.000484	0.00136	CcSEcCtD
Argatroban—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000483	0.00136	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000481	0.00484	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000479	0.00482	CbGpPWpGaD
Argatroban—Nausea—Raloxifene—osteoporosis	0.000478	0.00135	CcSEcCtD
Argatroban—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000474	0.00134	CcSEcCtD
Argatroban—Nausea—Ibandronate—osteoporosis	0.000473	0.00133	CcSEcCtD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000472	0.00476	CbGpPWpGaD
Argatroban—Feeling abnormal—Zoledronate—osteoporosis	0.00047	0.00132	CcSEcCtD
Argatroban—Cough—Estradiol—osteoporosis	0.00047	0.00132	CcSEcCtD
Argatroban—Constipation—Conjugated Estrogens—osteoporosis	0.00047	0.00132	CcSEcCtD
Argatroban—Pain—Conjugated Estrogens—osteoporosis	0.00047	0.00132	CcSEcCtD
Argatroban—Gastrointestinal pain—Zoledronate—osteoporosis	0.000466	0.00131	CcSEcCtD
Argatroban—F2—Hemostasis—ANXA2—osteoporosis	0.000464	0.00468	CbGpPWpGaD
Argatroban—F2—Hemostasis—PLEK—osteoporosis	0.000464	0.00468	CbGpPWpGaD
Argatroban—Nausea—Calcitriol—osteoporosis	0.000463	0.00131	CcSEcCtD
Argatroban—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000461	0.0013	CcSEcCtD
Argatroban—Hypersensitivity—Pamidronate—osteoporosis	0.00046	0.0013	CcSEcCtD
Argatroban—Chest pain—Estradiol—osteoporosis	0.000458	0.00129	CcSEcCtD
Argatroban—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000451	0.00455	CbGpPWpGaD
Argatroban—Abdominal pain—Zoledronate—osteoporosis	0.000451	0.00127	CcSEcCtD
Argatroban—Body temperature increased—Zoledronate—osteoporosis	0.000451	0.00127	CcSEcCtD
Argatroban—Diarrhoea—Risedronate—osteoporosis	0.000449	0.00127	CcSEcCtD
Argatroban—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000449	0.00127	CcSEcCtD
Argatroban—F2—Metabolism of proteins—TUBA1B—osteoporosis	0.000448	0.00452	CbGpPWpGaD
Argatroban—Dizziness—Ethinyl Estradiol—osteoporosis	0.000445	0.00126	CcSEcCtD
Argatroban—CYP3A5—Biological oxidations—CYP27A1—osteoporosis	0.000443	0.00447	CbGpPWpGaD
Argatroban—Confusional state—Estradiol—osteoporosis	0.000443	0.00125	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—osteoporosis	0.00044	0.00443	CbGpPWpGaD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000438	0.00442	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP27A1—osteoporosis	0.000437	0.00441	CbGpPWpGaD
Argatroban—Infection—Estradiol—osteoporosis	0.000437	0.00123	CcSEcCtD
Argatroban—Dizziness—Risedronate—osteoporosis	0.000434	0.00122	CcSEcCtD
Argatroban—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000434	0.00122	CcSEcCtD
Argatroban—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000434	0.00122	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—TNF—osteoporosis	0.000433	0.00436	CbGpPWpGaD
Argatroban—Tachycardia—Estradiol—osteoporosis	0.000429	0.00121	CcSEcCtD
Argatroban—Vomiting—Ethinyl Estradiol—osteoporosis	0.000428	0.00121	CcSEcCtD
Argatroban—Diarrhoea—Pamidronate—osteoporosis	0.000427	0.0012	CcSEcCtD
Argatroban—Rash—Ethinyl Estradiol—osteoporosis	0.000425	0.0012	CcSEcCtD
Argatroban—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000424	0.0012	CcSEcCtD
Argatroban—Headache—Ethinyl Estradiol—osteoporosis	0.000422	0.00119	CcSEcCtD
Argatroban—Hypersensitivity—Zoledronate—osteoporosis	0.00042	0.00118	CcSEcCtD
Argatroban—Vomiting—Risedronate—osteoporosis	0.000418	0.00118	CcSEcCtD
Argatroban—Rash—Risedronate—osteoporosis	0.000414	0.00117	CcSEcCtD
Argatroban—Dermatitis—Risedronate—osteoporosis	0.000414	0.00117	CcSEcCtD
Argatroban—Dizziness—Pamidronate—osteoporosis	0.000413	0.00116	CcSEcCtD
Argatroban—Headache—Risedronate—osteoporosis	0.000411	0.00116	CcSEcCtD
Argatroban—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000405	0.00114	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—CALCR—osteoporosis	0.000404	0.00407	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PTH1R—osteoporosis	0.000404	0.00407	CbGpPWpGaD
Argatroban—F2—Hemostasis—TLN1—osteoporosis	0.0004	0.00403	CbGpPWpGaD
Argatroban—Nausea—Ethinyl Estradiol—osteoporosis	0.0004	0.00113	CcSEcCtD
Argatroban—Vomiting—Pamidronate—osteoporosis	0.000397	0.00112	CcSEcCtD
Argatroban—F2—Hemostasis—VCL—osteoporosis	0.000395	0.00398	CbGpPWpGaD
Argatroban—Rash—Pamidronate—osteoporosis	0.000394	0.00111	CcSEcCtD
Argatroban—Dermatitis—Pamidronate—osteoporosis	0.000393	0.00111	CcSEcCtD
Argatroban—Dyspnoea—Estradiol—osteoporosis	0.000392	0.0011	CcSEcCtD
Argatroban—Headache—Pamidronate—osteoporosis	0.000391	0.0011	CcSEcCtD
Argatroban—Diarrhoea—Zoledronate—osteoporosis	0.00039	0.0011	CcSEcCtD
Argatroban—Nausea—Risedronate—osteoporosis	0.00039	0.0011	CcSEcCtD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000388	0.00391	CbGpPWpGaD
Argatroban—Dyspepsia—Estradiol—osteoporosis	0.000387	0.00109	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—IL1B—osteoporosis	0.000385	0.00388	CbGpPWpGaD
Argatroban—Gastrointestinal disorder—Estradiol—osteoporosis	0.000379	0.00107	CcSEcCtD
Argatroban—Dizziness—Zoledronate—osteoporosis	0.000377	0.00106	CcSEcCtD
Argatroban—Constipation—Estradiol—osteoporosis	0.000376	0.00106	CcSEcCtD
Argatroban—Pain—Estradiol—osteoporosis	0.000376	0.00106	CcSEcCtD
Argatroban—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000376	0.00106	CcSEcCtD
Argatroban—F2—GPCR ligand binding—PTH—osteoporosis	0.000375	0.00378	CbGpPWpGaD
Argatroban—Nausea—Pamidronate—osteoporosis	0.000371	0.00105	CcSEcCtD
Argatroban—F2—Signaling by GPCR—CALCR—osteoporosis	0.000367	0.0037	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PTH1R—osteoporosis	0.000367	0.0037	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CNR2—osteoporosis	0.000366	0.00369	CbGpPWpGaD
Argatroban—Dizziness—Conjugated Estrogens—osteoporosis	0.000363	0.00102	CcSEcCtD
Argatroban—Vomiting—Zoledronate—osteoporosis	0.000363	0.00102	CcSEcCtD
Argatroban—Feeling abnormal—Estradiol—osteoporosis	0.000362	0.00102	CcSEcCtD
Argatroban—Rash—Zoledronate—osteoporosis	0.00036	0.00101	CcSEcCtD
Argatroban—Gastrointestinal pain—Estradiol—osteoporosis	0.000359	0.00101	CcSEcCtD
Argatroban—Dermatitis—Zoledronate—osteoporosis	0.000359	0.00101	CcSEcCtD
Argatroban—F2—Metabolism of proteins—RPL24—osteoporosis	0.000358	0.00361	CbGpPWpGaD
Argatroban—Headache—Zoledronate—osteoporosis	0.000357	0.00101	CcSEcCtD
Argatroban—F2—Folate Metabolism—TNF—osteoporosis	0.000352	0.00355	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—IL6—osteoporosis	0.000349	0.00352	CbGpPWpGaD
Argatroban—Vomiting—Conjugated Estrogens—osteoporosis	0.000349	0.000984	CcSEcCtD
Argatroban—Abdominal pain—Estradiol—osteoporosis	0.000347	0.00098	CcSEcCtD
Argatroban—Body temperature increased—Estradiol—osteoporosis	0.000347	0.00098	CcSEcCtD
Argatroban—Rash—Conjugated Estrogens—osteoporosis	0.000346	0.000976	CcSEcCtD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000346	0.00349	CbGpPWpGaD
Argatroban—Dermatitis—Conjugated Estrogens—osteoporosis	0.000346	0.000975	CcSEcCtD
Argatroban—F2—GPCR ligand binding—WNT1—osteoporosis	0.000344	0.00347	CbGpPWpGaD
Argatroban—Headache—Conjugated Estrogens—osteoporosis	0.000344	0.00097	CcSEcCtD
Argatroban—Nausea—Zoledronate—osteoporosis	0.000339	0.000955	CcSEcCtD
Argatroban—F2—Hemostasis—RAP1A—osteoporosis	0.00033	0.00333	CbGpPWpGaD
Argatroban—Nausea—Conjugated Estrogens—osteoporosis	0.000326	0.00092	CcSEcCtD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000325	0.00328	CbGpPWpGaD
Argatroban—Hypersensitivity—Estradiol—osteoporosis	0.000324	0.000913	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—MGLL—osteoporosis	0.000321	0.00323	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—TLN1—osteoporosis	0.000315	0.00317	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—PTHLH—osteoporosis	0.000311	0.00314	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000311	0.00313	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—REN—osteoporosis	0.000303	0.00305	CbGpPWpGaD
Argatroban—Diarrhoea—Estradiol—osteoporosis	0.000301	0.000848	CcSEcCtD
Argatroban—F2—Hemostasis—FGA—osteoporosis	0.000299	0.00302	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MGLL—osteoporosis	0.000291	0.00294	CbGpPWpGaD
Argatroban—Dizziness—Estradiol—osteoporosis	0.000291	0.000819	CcSEcCtD
Argatroban—F2—Folate Metabolism—IL6—osteoporosis	0.000284	0.00286	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—POMC—osteoporosis	0.000281	0.00283	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—TNF—osteoporosis	0.00028	0.00282	CbGpPWpGaD
Argatroban—Vomiting—Estradiol—osteoporosis	0.000279	0.000788	CcSEcCtD
Argatroban—Rash—Estradiol—osteoporosis	0.000277	0.000781	CcSEcCtD
Argatroban—Dermatitis—Estradiol—osteoporosis	0.000277	0.000781	CcSEcCtD
Argatroban—Headache—Estradiol—osteoporosis	0.000275	0.000776	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CALCA—osteoporosis	0.000274	0.00276	CbGpPWpGaD
Argatroban—F2—Hemostasis—FGB—osteoporosis	0.000272	0.00274	CbGpPWpGaD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000264	0.00266	CbGpPWpGaD
Argatroban—Nausea—Estradiol—osteoporosis	0.000261	0.000736	CcSEcCtD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000251	0.00253	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000248	0.0025	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000248	0.0025	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SOST—osteoporosis	0.00024	0.00241	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000239	0.00241	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	0.000233	0.00235	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	0.00023	0.00232	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IL6—osteoporosis	0.000226	0.00227	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CALCR—osteoporosis	0.000217	0.00218	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTH1R—osteoporosis	0.000217	0.00218	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PTH—osteoporosis	0.000212	0.00214	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CNR2—osteoporosis	0.000207	0.00208	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000206	0.00208	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000204	0.00205	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000203	0.00205	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PTH—osteoporosis	0.000193	0.00194	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—ACE—osteoporosis	0.000189	0.0019	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000188	0.0019	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CNR2—osteoporosis	0.000188	0.00189	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—WNT1—osteoporosis	0.000177	0.00178	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PTHLH—osteoporosis	0.000176	0.00177	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MGLL—osteoporosis	0.000172	0.00173	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LRP5—osteoporosis	0.000168	0.00169	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LRP6—osteoporosis	0.000161	0.00162	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PTHLH—osteoporosis	0.00016	0.00161	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CALCA—osteoporosis	0.000155	0.00156	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000151	0.00152	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000143	0.00144	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—POMC—osteoporosis	0.000143	0.00144	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CALCA—osteoporosis	0.000141	0.00142	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—POMC—osteoporosis	0.00014	0.00141	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TLN1—osteoporosis	0.000136	0.00137	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—FDPS—osteoporosis	0.000132	0.00133	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PKM—osteoporosis	0.000132	0.00133	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GPD2—osteoporosis	0.000125	0.00126	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PGLS—osteoporosis	0.000125	0.00126	CbGpPWpGaD
Argatroban—F2—Hemostasis—IGF1—osteoporosis	0.000123	0.00124	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000123	0.00123	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—LEP—osteoporosis	0.000117	0.00118	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—P4HB—osteoporosis	0.000117	0.00118	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PNP—osteoporosis	0.000114	0.00115	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ATIC—osteoporosis	0.000114	0.00115	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTH—osteoporosis	0.000114	0.00115	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RAP1A—osteoporosis	0.000112	0.00113	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CNR2—osteoporosis	0.000111	0.00112	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.00011	0.00111	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—ADCY5—osteoporosis	0.00011	0.00111	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NFATC1—osteoporosis	0.000109	0.0011	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	0.000108	0.00109	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DKK1—osteoporosis	0.000108	0.00109	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	0.000107	0.00108	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—WNT1—osteoporosis	0.000104	0.00105	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGA—osteoporosis	0.000101	0.00102	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—POMC—osteoporosis	0.000101	0.00102	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—ADCY5—osteoporosis	0.0001	0.00101	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—OXCT1—osteoporosis	9.73e-05	0.000981	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CA2—osteoporosis	9.73e-05	0.000981	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—IGF1—osteoporosis	9.7e-05	0.000977	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MGLL—osteoporosis	9.49e-05	0.000956	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTHLH—osteoporosis	9.43e-05	0.000951	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BMP2—osteoporosis	9.43e-05	0.000951	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGB—osteoporosis	9.23e-05	0.00093	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PSMA2—osteoporosis	8.91e-05	0.000898	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PSMA5—osteoporosis	8.91e-05	0.000898	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CALCA—osteoporosis	8.3e-05	0.000837	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—POMC—osteoporosis	8.1e-05	0.000816	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—IDH2—osteoporosis	8.07e-05	0.000813	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP27A1—osteoporosis	7.58e-05	0.000764	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KL—osteoporosis	7.54e-05	0.00076	CbGpPWpGaD
Argatroban—F2—Hemostasis—TGFB1—osteoporosis	7.39e-05	0.000745	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ACP5—osteoporosis	7.38e-05	0.000743	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—POMC—osteoporosis	7.35e-05	0.000741	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6R—osteoporosis	7.17e-05	0.000723	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TPI1—osteoporosis	6.86e-05	0.000691	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—POMC—osteoporosis	6.51e-05	0.000656	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—P4HB—osteoporosis	6.45e-05	0.00065	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GAPDH—osteoporosis	6.33e-05	0.000638	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—RAP1A—osteoporosis	6.16e-05	0.000621	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—FDPS—osteoporosis	6.14e-05	0.000619	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PKM—osteoporosis	6.14e-05	0.000619	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ADCY5—osteoporosis	5.91e-05	0.000595	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PGLS—osteoporosis	5.82e-05	0.000586	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPD2—osteoporosis	5.82e-05	0.000586	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SPP1—osteoporosis	5.71e-05	0.000576	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ATIC—osteoporosis	5.32e-05	0.000536	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PNP—osteoporosis	5.32e-05	0.000536	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IRS2—osteoporosis	5.17e-05	0.000521	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LEP—osteoporosis	5.06e-05	0.00051	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ENO1—osteoporosis	4.98e-05	0.000502	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PSMA2—osteoporosis	4.91e-05	0.000495	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PSMA5—osteoporosis	4.91e-05	0.000495	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ESR1—osteoporosis	4.83e-05	0.000487	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—OXCT1—osteoporosis	4.53e-05	0.000456	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CA2—osteoporosis	4.53e-05	0.000456	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IRS1—osteoporosis	4.51e-05	0.000455	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MGLL—osteoporosis	4.41e-05	0.000444	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—POMC—osteoporosis	4.34e-05	0.000438	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6R—osteoporosis	4.24e-05	0.000427	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF1—osteoporosis	4.18e-05	0.000421	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP19A1—osteoporosis	3.98e-05	0.000401	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—IDH2—osteoporosis	3.75e-05	0.000378	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.53e-05	0.000355	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ACP5—osteoporosis	3.43e-05	0.000346	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ADCY5—osteoporosis	3.25e-05	0.000328	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GPX1—osteoporosis	3.24e-05	0.000327	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—osteoporosis	3.2e-05	0.000322	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TPI1—osteoporosis	3.19e-05	0.000321	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—P4HB—osteoporosis	3e-05	0.000302	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTHFR—osteoporosis	2.99e-05	0.000302	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GAPDH—osteoporosis	2.94e-05	0.000297	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—RAP1A—osteoporosis	2.87e-05	0.000289	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MYC—osteoporosis	2.51e-05	0.000253	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFB1—osteoporosis	2.51e-05	0.000252	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—POMC—osteoporosis	2.39e-05	0.000241	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ENO1—osteoporosis	2.32e-05	0.000233	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PSMA5—osteoporosis	2.28e-05	0.00023	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PSMA2—osteoporosis	2.28e-05	0.00023	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—osteoporosis	1.89e-05	0.00019	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.85e-05	0.000187	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ADCY5—osteoporosis	1.51e-05	0.000152	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPX1—osteoporosis	1.51e-05	0.000152	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTHFR—osteoporosis	1.39e-05	0.00014	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—POMC—osteoporosis	1.11e-05	0.000112	CbGpPWpGaD
